Biotech · Private company
Resverlogix Corp
Track this companyFree. Adds Resverlogix Corp to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- RVX000222Phase 2 · AtherosclerosisClinicalTrials.gov · fetched Nov 12, 2026
- RVX000222Phase 2 · DyslipidemiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery DiseasePHASE2 · COMPLETED · started Dec 1, 2009ClinicalTrials.gov NCT01058018 · fetched Nov 12, 2026
- Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL CholesterolPHASE1_PHASE2 · COMPLETED · started Sep 1, 2008ClinicalTrials.gov NCT00768274 · fetched Nov 12, 2026